Contact
Please use this form to send email to PR contact of this press release:
Amphera Recruits First Patients to Pivotal Phase II/III study of MesoPher to Treat Pleural Mesothelioma
TO:
Please use this form to send email to PR contact of this press release:
Amphera Recruits First Patients to Pivotal Phase II/III study of MesoPher to Treat Pleural Mesothelioma
TO: